UniSuper Management’s GSK GSK Stock Holding History

UniSuper Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-89,631	Closed	-$3.66M	–	698
2024 Q3	$3.66M	Sell	89,631 -6,851	-7%	-$280K	0.03%	278
2024 Q2	$3.71M	Buy	+96,482	New	+$4.06M	0.03%	249

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UniSuper Management's GSK Position: Q4 2024 in Review

UniSuper Management sold out of GSK (GSK) in Q4 2024, closing a stake of 89,631 shares — an estimated $3.66M sold.

UniSuper Management first reported a position in GSK in Q2 2024 and held it in 2 quarters. The position peaked at $3.71M in Q2 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

UniSuper Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
UniSuper Management sold 89,631 GSK shares in Q4 2024, an estimated $3.66M.
UniSuper Management first reported a position in GSK in Q2 2024 and held it in 2 quarters.
UniSuper Management's GSK position peaked at $3.71M in Q2 2024.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on UniSuper Management's 13F filing for Q4 2024, filed 12 Feb 2025.